CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Shareholder vote results
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $2.11 ($21,100)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
Page 4 of 19 · 362 filings